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ABSTRACT
SUSAN CASPER: The Global Burden of Anthropogenic Ozone and
Particulate Matter Air Pollution on Premature Human Mortality.
(Under the direction of J. Jason West.)
Tropospheric ozone and fine particulate matter (PM) have increased significantly
since preindustrial times and have been demonstrated to cause negative health im-
pacts, including cardiovascular and respiratory mortality. Previous estimates of the
global burden of outdoor PM on premature human mortality have been based on
air quality measurements. Here, we use results from a global atmospheric chemistry
and transport model simulation of ozone and PM concentrations in the preindustrial
(1860) and the present (2000) to drive human mortality estimates. This method
includes rural areas where measurements are often unavailable and avoids making
assumptions for background air pollution. Depending on the concentration thresh-
old applied, anthropogenic ozone is associated with about 282,000 to 362,000 global
premature cardiopulmonary mortalities, with uncertainty ranging from 135,000 to
551,000 mortalities. Anthropogenic PM is associated with about 1.3 to 2.4 mil-
lion global premature cardiopulmonary and lung cancer mortalities, with uncertainty
ranging from 465,000 to 3.8 million mortalities.
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CHAPTER 1
INTRODUCTION
Human influence on the atmosphere has increased substantially since industrializa-
tion. The changing composition of the atmosphere resulting from human development
has important consequences for the environment and human health. This research
aims to quantify the impact of human-induced, or anthropogenic, outdoor air pollu-
tion on human health. Specifically, this research examines the annual global burden of
mortality caused by anthropogenic ozone and fine particulate matter (PM), two of the
most ubiquitous and deleterious air pollutants. By employing a global atmospheric
chemistry model to simulate ozone and PM concentrations in urban and rural areas,
it improves on previous methods used to estimate the global burden of disease due to
monitored urban air pollution. This work also illustrates the geographical distribu-
tion of excess mortalities due to global anthropogenic air pollution, highlighting local
areas where improvements to air quality may be particularly effective at reducing
air pollution-related mortality. This introduction will provide general background on
anthropogenic contributions to air pollution and trends over time, the health effects
resulting from exposure to air pollution, and the objectives of this study. Methodol-
ogy, results, and conclusions and implications will then be discussed.
1.1 Background
While ozone in the stratosphere shields damaging ultraviolet (UV) radiation from
reaching the surface of the Earth, tropospheric, or ground-level, ozone causes dele-
terious health effects. Tropospheric ozone is not emitted directly, but is formed in
the troposphere through reactions between precursors that take place in sunlight.
Emission of ozone precursors, nitrogen oxides and volatile organic compounds, can
be natural or anthropogenic. While natural precursor emissions may also change
throughout time as a result of changing climate, anthropogenic precursor emissions
have increased substantially in the last century, leading to a large increase in ground-
level ozone. The main anthropogenic sources of ozone precursors are industrial facil-
ities and motor vehicles.
PM is both emitted directly and formed indirectly through reaction in the atmo-
sphere. Coarse PM, PM greater than about 2.5 µm in diameter, is largely transferred
to the atmosphere by natural physical processes, such as wind-produced dust and
sea salt. Conversely, fine PM, PM less than 2.5 µm in diameter, is emitted by an-
thropogenic sources or produced by reaction of gaseous emissions, such as nitrogen
and sulfur oxides, in the atmosphere. The main anthropogenic sources of fine PM
are motor vehicles and power plants. Fine PM is associated with more deleterious
health effects than coarse PM, because these tiny particles can penetrate deep into
the lungs and may consist of more toxic materials [Pope & Dockery, 2006]. This
paper, therefore, focuses on fine PM, or PM2.5, which will hereafter be referred to as
PM. Any references to coarse PM will be explicitly stated.
Ground-level concentrations of ozone and PM have increased substantially since
preindustrial times [Volz & Kley, 1988; Staehelin et al., 2001; Schultz et al., 2006;
Horowitz, 2006; Ginoux et al., 2006]. While the greatest increases in ozone and PM
concentrations have occurred in heavily industrialized urban areas, increases in back-
ground concentrations have also been observed in remote regions. Because the lifetime
of ozone (and its precursors) is sufficiently long that it can be transported between
continents, the global background concentration of ozone has roughly doubled that in
preindustrial times [Volz & Kley, 1988; Akimoto, 2003; Vingarzan, 2004]. Though the
lifetime of PM is shorter than that of ozone, it is long enough that it can distribute
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to form elevated regional background concentrations [Akimoto, 2003].
Associations between these pollutants and human health endpoints, found by
short-term and long-term epidemiology studies, form the basis for regulatory action
in the US, Europe, and many other countries. In the US, both ozone and PM are
regulated by National Ambient Air Quality Standards (NAAQS), which are set by
the US Environmental Protection Agency (EPA) to protect human health without
regard to cost. NAAQS were first established in 1970 and are continually strengthened
over time to reflect new scientific understanding. In 2008, the daily 8-hr. maximum
standard for ozone was lowered from 80 parts per billion (ppb) to 75 ppb. While the
original NAAQS for PM was based on PM10, or all PM less than 10 µm in diameter,
a separate standard for fine PM was set in 1997 after linkages were found between
fine PM and health problems, such as increased hospital admissions, emergency room
visits, and premature death for people with lung and heart disease. The annual
average PM10 standard was eventually revoked in 2006 because evidence does not
suggest a link between long-term exposure to coarse PM and deleterious health effects,
although the 24-hr. average standard of 150 µg/m3 was retained. The current annual
average standard for fine PM is 15 µg/m3.
1.2 Health Effects of Air Pollution
Both ozone and PM have been demonstrated to cause negative health impacts,
including premature mortality. Ozone has been associated with premature mortality
in many city-specific daily time-series studies. Meta-analyses of these studies have
found a consistent relationship between ozone and daily mortality [Bell et al., 2005;
Ito et al., 2005; Levy et al., 2005]. Recently, larger daily time-series studies have used
large datasets of urban regions in the US and Europe, with consistent results [Bell
et al., 2004, 2005; Gryparis et al., 2004]. While these studies do not strongly suggest
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the cause of death, they show that the relationship between ozone concentration and
mortality holds over a wide range of concentrations. On an individual level, there may
be biological concentration thresholds of exposure above or below which no health
effects occur. However, to date, there is no clear evidence from these studies of
population-level low-concentration or high-concentration thresholds [Bell et al., 2006;
Gryparis et al., 2004].
Daily time-series studies also show strong relationships between PM and mortal-
ity. Some studies have utilized sudden changes in PM concentrations to document
associated decreases in mortality [Pope et al., 1992; Clancy et al., 2002; Hedley et al.,
2002]. Long-term cohort studies have also connected PM with mortality by following
the exposure of a group of participants for years. Three long-term cohort studies in
the US [Dockery et al., 1993; Pope et al., 2002; Laden et al., 2006] and one in Europe
[Hoek et al., 2002] demonstrated that PM has a much greater effect on mortality in
the long term than the daily time-series studies suggest. These studies show that
the relationship between PM and mortality holds over a wide range of concentrations
[Laden et al., 2006]. Like ozone, there is no evidence to date of population-level
low-concentration or high-concentration thresholds [Schwartz & Zanobetti, 2000].
1.3 Objectives
One recent study examined the global burden of mortality due to outdoor air pol-
lution [Cohen et al., 2004, 2005]. This study estimated that about 800,000 premature
mortalities, or about 1.2% of all deaths, occur per year globally due to outdoor fine
PM in urban areas only. Their estimate was based on PM only, ignoring ozone. In
addition, since this study relied on PM measurements, it included only urban areas,
where monitors are most often located, and excluded rural areas. The population
included in this study was about 30% of the total global population. In cities where
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no monitor data were available, PM concentrations were inferred using economet-
ric methods. Because anthropogenic emissions have increased both ozone and PM
outside of urban areas, there is reason to believe that Cohen et al. [2004] may sub-
stantially underestimate the global burden of anthropogenic air pollution on human
mortality.
This study aims to improve upon the method used for estimating the number of
premature mortalities resulting from global anthropogenic air pollution. Specifically,
we use results from global atmospheric chemistry and transport model (MOZART-2)
simulations of ozone and PM concentrations in 1860, the preindustrial base case, and
2000, the present day case, to drive human mortality estimates. Global air qual-
ity models are often used to simulate past, present, and future emission scenarios.
Recent studies have used global air quality models to estimate radiative climate forc-
ing of trace gases and particles [Forster et al., 2007] and the health burden due to
future changes in emissions [West et al., 2006, 2007; Jacobson, 2008] or to changes
in one sector’s emissions [Corbett et al., 2007]. Global air quality models have not
been used previously to quantify the global burden of anthropogenic air pollution on
human mortality. Here, the use of an air quality model allows estimation of mor-
tality in regions for which ground-level concentration measurements are unavailable
and omitted from estimates based on direct air quality measurements. In addition,
by simulating the preindustrial base case, we are able to isolate the mortality due
to anthropogenic pollution and avoid making assumptions for background ozone and
PM concentrations.
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CHAPTER 2
METHODOLOGY
2.1 Experimental Design
Results of a global air quality model are used to derive the anthropogenic con-
tribution to ground-level ozone and PM concentrations. Anthropogenic pollution is
defined as the geographically-distributed difference in ozone and PM concentrations
simulated for the present (2000) and preindustrial (1860). Health impact functions
from the epidemiological literature for both ozone and PM are used to relate pollu-
tant concentrations with premature human mortality. Results are plotted on a world
map to illustrate geographically-distributed mortality. Finally, sensitivities to varying
concentration-response factors and health effect thresholds are examined.
2.2 Health Impact Functions
Health impact functions relate air pollutant concentrations with changes in inci-
dence of human health endpoints. Epidemiology studies have found that the natural
logarithm of relative risk increases roughly linearly with concentration, which is ex-
pressed mathematically by Equation 2.1.
RR = expβ∆X (2.1)
where RR is relative risk and β is the concentration-response factor (fraction excess
mortalities per unit change in pollutant concentration, X ).
The health impact function derived by epidemiology studies and used in this study
for both ozone and PM is:
∆Mort = y0(1− exp−β∆X)Pop (2.2)
where ∆Mort is the change in human mortalities due to a change in pollutant con-
centration (∆X ), y0 is the baseline mortality rate for a given population, β is the
concentration-response factor, X is the pollutant concentration, and Pop is the to-
tal population exposed. The derivation of this function and the decision to use this
function over others in the literature (e.g. Ostro [2004]) is described in Appendix A.
2.2.1 Concentration-Response Factor (CRF)
Concentration-Response Factors (CRFs) relate a unit change in air pollution with
relative risk, where relative risk is the ratio of the probability of health endpoint
incidence in the exposed group vs. the unexposed group (Appendix A). Where the
natural logarithm of relative risk increases linearly with concentration, CRFs are
calculated by the following equation, which is a transformation of the equation for
relative risk (Equation 2.1):
β =
lnRR
∆X
(2.3)
where β is the CRF, RR is relative risk, and ∆X is the change in concentration
associated with the change in relative risk.
For ozone mortality, CRFs are calculated from the 8-hour daily maximum ozone
relative risks from Bell et al. [2004], because it was based on 95 US cities and, there-
fore, was not subject to publication bias that may influence meta-analyses of single-
city studies (e.g. Bell et al. [2005]; Ito et al. [2005]; Levy et al. [2005]). Bell et al.
[2004] calculated a national average relative rate of mortality associated with short-
term exposure to ambient ozone. For each 10 ppb increase in 8-hour daily maximum
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Table 2.1: Relative risks for 1979-1983, 1999-2000, and the average of the two time
periods from Pope et al. [2002] with 95% confidence intervals (CI)
Cause of Mortality 1979‐1983 1999‐2000 Average
All‐cause 1.04 (1.01‐1.08) 1.06 (1.02‐1.10) 1.06 (1.02‐1.11)
Cardiopulmonary 1.06 (1.02‐1.10) 1.08 (1.02‐1.14) 1.09 (1.03‐1.16)
Lung Cancer 1.08 (1.01‐1.16) 1.13 (1.04‐1.22) 1.14 (1.04‐1.23)
ozone, total daily non-accidental mortality increased by 0.52% (95% posterior interval
[PI], 0.27%-0.77%) and daily cardiovascular and respiratory mortality increased by
0.64% (95% PI, 0.31%-0.98%).
For PM mortality, CRFs are calculated from annual average PM relative risks
from Pope et al. [2002]. The Pope et al. [2002] study was chosen because it has the
largest sample size (about 500,000 adults) of the cohort studies. Associations between
long-term exposure to PM and all-cause, cardiopulmonary, and lung cancer mortality
were based on monitored PM data (ranging from 7.5-30 µg/m3) along with data on
individual risk factors from the American Cancer Society (ACS) Cancer Prevention
II study. Relative risks associated with PM exposure were reported for 1979-1983,
for 1999-2000 and for the integrated average of the two periods. While the results
for 1979-1983 are reported in the abstract and conclusion, we chose to use the results
from the average of 1979-1983 and 1999-2000 to calculate mortality estimates, because
they were thought to be less sensitive to the specific conditions influencing each time
period. For a 10 µg/m3 increase in PM, total, cardiopulmonary, and lung cancer
mortalities increased by 6% (95% CI, 2%-11%), 9% (3%-16%), and 14% (4%-23%)
for the average of the two time periods (Table 2.1). We also examine the sensitivity
of mortality estimates to varying CRFs (Section 3.3).
These relative risks were estimated in the US, and similar results have been demon-
strated in Europe for both PM [Hoek et al., 2002] and ozone [Anderson et al., 2004].
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To date, no long-term PM cohort study has been conducted in the developing world,
but short-term PM and ozone studies in developing nations have found relationships
comparable to short-term studies in North America and Europe [HEI International
Scientific Oversight Committee, 2004]. However, these studies are less conclusive than
those conducted in North America and Europe because they generally each focus on
one city and may not be representative of the developing world as a whole. Short-
term studies are further subject to uncertainty concerning the timing of exposure and
resulting health endpoints. Since no evidence to the contrary yet exists, it is assumed
for this study that mortality relationships found in the US are valid globally. This as-
sumption is further supported by evidence that concentration-mortality relationships
do not vary significantly by sex, age, and race [Zanobetti et al., 2000; Pope et al.,
2002; Bell et al., 2004], though some sensitive populations may be at a higher risk.
2.2.2 Pollutant Concentrations
This study uses simulations of ozone and PM concentrations produced with the
Model of Ozone and Related Chemical Tracers, version 2 (MOZART-2) [Horowitz
et al., 2003] with meteorological inputs from the middle atmospheric version of the Na-
tional Center for Atmospheric Research (NCAR) Community Climate Model (MACCM3)
[Kiehl et al., 1998]. MOZART-2 has a horizontal resolution of 2.8◦ latitude by 2.8◦ lon-
gitude with 34 vertical levels. It includes 63 chemical species with detailed chemistry
for tropospheric ozone, nitrogen oxides, and hydrocarbons. Simulated aerosol species
are sulfate, nitrate, ammonium, black carbon, organic carbon (includes primary or-
ganic carbon and secondary organic aerosols), and dust. Here, fine PM concentration
is defined as the total concentration of sulfate (SO4), nitrate (NO3), black carbon
(BC), and organic carbon (OC) aerosols. Ozone and PM concentrations in the first
vertical level only were used to simulate exposure at the surface of the Earth.
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Present day (2000) and preindustrial (1860) ozone and PM concentrations used for
this study are simulated and described fully by Horowitz [2006]. For the preindustrial
case, fossil fuel burning was set to zero, emissions from burning of biofuels, savannah,
tropical forests, and agricultural waste were assumed to be 10% of 1990 values, and
natural emissions (including dust) were identical for both simulations. Present day
emissions are from EDGAR v2.0 [Olivier et al., 1996]. Compared with the preindus-
trial, the present day burden of tropospheric ozone has increased by 50% and sulfate
and carbonaceous PM burdens have increased by factors of 3 and 6 [Horowitz, 2006].
For this study, the anthropogenic contribution to ozone and PM was defined as the
difference between the simulated present day and preindustrial concentrations.
Horowitz et al. [2003] and Horowitz [2006] evaluated ozone above the surface. Sur-
face ozone concentrations simulated for 2000 were further compared with observations
from one year between 1998-2004 (based on data availability) to determine whether an
overall or regional bias exists (Appendix B). Modeled concentrations were compared
with the Climate Modeling and Diagnostics Laboratory (CMDL) monitoring network
(mean bias=2.5ppb) for remote locations around the world, Clean Air Status and
Trends Network (CASTNet) (mean bias=2.9ppb) for the US, the European Monitor-
ing and Evaluation Programme (EMEP) (mean bias=-0.2ppb) for Europe, and the
Acid Deposition Monitoring Network in East Asia (EANET) (mean bias=0.4ppb) for
Japan. These comparisons showed that surface ozone is well simulated by MOZART-2
and that no bias correction is necessary.
The PM concentration used in this study is the sum of the concentrations of sim-
ulated PM components (OC, BC, SO4, and NO3), which are assumed to be 2.5 µm or
less in diameter. Modeled surface PM concentrations were compared with observa-
tions by Ginoux et al. [2006] and were generally found to be estimated within a factor
of 2 in remote locations, Europe, and the US, with a tendency to be overestimated.
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Table 2.2: The population-weighted annual average 8-hr. daily maximum ozone
concentrations (ppb) and annual average PM concentrations (µg/m3), using βavg.
[Pope et al., 2002] for the Horowitz [2006] simulations of 1860 and 2000.
19 81 41 08 16 73
Ozone (ppb) OC (µg/m3) BC (µg/m3) NO3 (µg/m
3) SO4 (µg/m
3) Total PM (µg/m3)
1860 2000 1860 2000 1860 2000 1860 2000 1860 2000 1860 2000
Africa 11.64 19.75 0.36 3.18 0.05 0.57 0.00 0.07 0.32 2.10 0.73 5.92
North America 21.54 47.82 0.83 2.10 0.06 0.61 0.00 0.46 0.24 3.87 1.14 7.03
Europe 22.10 35.55 0.44 5.21 0.04 1.21 0.00 1.17 0.23 4.44 0.72 12.03
Asia . . 0 54. 6 48. 0 09. 1 95. 0 01. 1 00. 0 30. 7 31. 0 93. .
South America 13.46 25.08 0.24 2.29 0.03 0.47 0.00 0.03 0.55 2.29 0.83 5.09
Oceania 14.58 24.47 0.19 0.49 0.01 0.09 0.00 0.01 0.58 1.56 0.79 2.16
World 18.66 36.99 0.51 5.25 0.07 1.47 0.00 0.78 0.31 5.67 0.89 13.17
The change in ozone and PM concentrations from preindustrial to present day
was presented by Horowitz [2006] and is shown geographically-distributed in Figure
2.1. Table 2.2 shows the population-weighted surface concentrations of ozone and
PM in each of six continents and for the whole world in 1860 and 2000. The global
population-weighted annual average 8-hr. daily maximum ozone increased by 28.3
ppb (from 18.7 ppb in 1860 to 37.0 ppb in 2000) and the global population-weighted
annual average PM increased by 12.3 µg/m3 (from 0.9 µg/m3 in 1860 to 13.2 µg/m3
in 2000).
2.2.3 Population
Spatially-distributed population is based on the 2006 population from the LandScan
database [Oak Ridge National Laboratory, 2008], which apportions population to grid
cells based on likelihood coefficients, such as proximity to roads, slope, land cover,
and nighttime lights. Fine resolution LandScan data (30” by 30”) was then mapped
onto the coarse MOZART-2 grid (Appendix C). Since the Bell et al. [2004] included
the total population and Pope et al. [2002] study included only individuals at least
30 years of age, it is assumed for this study that the population exposed to ozone
is the whole population, while the population exposed to PM is the population aged
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Figure 2.1: Spatial distribution of the change in (top) annual average 8-hr. daily
maximum ozone concentrations (ppb) and (bottom) annual average PM (µg/m3)
from the Horowitz [2006] simulations of 1860 to 2000.
30 and older. The fraction of the population aged 30 and older was provided by the
World Health Organization [World Health Organization, 2004] for 14 world regions
(Appendix C). When a gridcell contained portions of more than one country within
it, an area-weighted average of the fraction of the population aged 30 and older was
calculated using a Geographic Information System (GIS).
2.2.4 Baseline Mortality Rates
Baseline rates of all-cause, non-accidental, cardiopulmonary, and lung cancer mor-
tality were provided by the World Health Organization’s 2004 World Health Report
[World Health Organization, 2004] for 14 world regions and for 66 individual coun-
tries, and mapped onto the MOZART-2 grid. The data for individual countries are
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categorized by broad age ranges with no cutoff at age 30. Therefore, mortality rates
for the population aged 25 and older were used, and it was assumed that, as a whole,
the population aged 25-29 reacts similarly to PM exposure as the population aged 30
and older in the Pope et al. [2002] study. When country-specific data was not avail-
able, population-weighted average mortality rates for the remaining countries in each
of 14 world regions were back-calculated using the WHO regional baseline mortality
rates. When a gridcell contained portions of more than one country within it, an
area-weighted average mortality rate was calculated using a GIS. Mapped baseline
mortality rates are shown in Appendix D.
2.3 Mortality Calculation
Equation 2.2 is applied in each grid cell to calculate premature mortalities sepa-
rately for ozone and PM, using the exposed population of that grid cell and the cor-
responding country-specific baseline mortality rates. Non-accidental and cardiopul-
monary mortality is calculated for ozone based on the relative risk estimates by Bell
et al. [2004]. All-cause (includes accidental and non-accidental), cardiopulmonary,
and lung cancer mortality are calculated for PM based on the relative risk estimates
by Pope et al. [2002]. While calculated cardiopulmonary and lung cancer mortali-
ties are additive, they are each a subset of non-accidental and all-cause mortality.
Therefore, non-accidental and all-cause mortality calculations are not additive.
For ozone, premature mortalities are calculated each day based on the difference
between 1860 and 2000 8-hr. daily maximum ozone concentrations. Since it is applied
on each day, β values are divided by 365.25 days per year. Daily premature mortalities
due to ozone are then summed to yield mortalities per year due to short-term ozone
exposure. Premature mortalities due to PM are calculated based on the differences
in annual average PM concentrations between 1860 and 2000.
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While the epidemiological literature provides no evidence for low-concentration
thresholds for either ozone or PM [Schwartz & Zanobetti, 2000], the exposure-response
relationship at low concentrations are uncertain. Therefore, results are calculated
assuming no low-concentration threshold and assuming a low-concentration threshold
for both ozone and PM. Below these thresholds, changes in ozone and PM are assumed
to have no effect on human mortality. For ozone, a threshold of 25 ppb, or roughly
the current background concentration, was applied. The threshold for PM was set
at 7.5 µg/m3, the lowest value included in the Pope et al. [2002] study. Cohen et al.
[2004, 2005] also used a low-concentration threshold of 7.5 µg/m3 in the estimation
of global mortality due to urban PM. The threshold in Cohen et al. [2004, 2005],
however, applied to total PM2.5, while here the threshold applies only to the species
included in our definition of simulated PM2.5 (sulfates, nitrates, organic carbon, and
black carbon). Using a threshold replaces the simulated preindustrial concentrations,
since preindustrial concentrations are almost always below these levels.
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CHAPTER 3
RESULTS AND DISCUSSION
3.1 Premature Mortalities due to Anthropogenic Ozone
Premature mortalities resulting from short-term ozone exposure are shown in Table
3.1. Here, the 95% posterior intervals (PI) represent the reported uncertainty in the
CRF only and do not include uncertainty from other sources, which are described
in Section 4. With no concentration threshold, anthropogenic ozone is estimated to
cause abut 640,000 (95% PI, 411,000-857,000) non-accidental and 362,000 (95% PI,
173,000-551,000) cardiopulmonary mortalities worldwide. When a low-concentration
threshold of 25 ppb is assumed, however, global non-accidental and cardiopulmonary
mortalities are reduced by about 20%. Over 60% of ozone mortalities occur in Asia,
which is densely populated and highly polluted. Contrastingly, only 6% of ozone
mortalities occur in North America. About 19% of non-accidental ozone mortalities
but only 11% of cardiopulmonary ozone mortalities occur in Africa. This discrepancy
is mainly due to the high baseline non-accidental mortality rates, but relatively low
baseline cardiopulmonary mortality rates in Africa.
Figures 3.1 and 3.2 show the geographic distribution of non-accidental and car-
diopulmonary mortalities due to anthropogenic ozone. Mortalities are most dense in
highly populated areas, particularly in China and India. When mortalities are nor-
malized to population, as shown on the right side of Figures 3.1 and 3.2, the ozone
mortality rates per 1 million people are more evenly distributed across the globe.
Non-accidental mortalities per 1 million people are highest in Africa, where baseline
mortality rates are high, and northern India, where modeled ozone concentrations
Table 3.1: Annual premature non-accidental and cardiopulmonary mortalities result-
ing from short-term anthropogenic ozone exposure. Mortalities are based on CRFs
from Bell et al. [2004] and 95% posterior intervals are shown next to each estimate.
threshold (ppb) 0 25 0 25
Africa 123 (79 ‐ 165) 99 (64 ‐ 133) 40 (19 ‐ 60) 32 (15 ‐ 49)
North America 40 (26 ‐ 54) 34 (22 ‐ 45) 23 (11 ‐ 35) 19 (9 ‐ 30)
Non‐Accidental (000s) Cardiopulmonary (000s)
Europe 61 (39 ‐ 82) 47 (30 ‐ 63) 44 (21 ‐ 68) 34 (16 ‐ 51)
Asia 396 (255 ‐ 530) 310 (199 ‐ 415) 244 (117 ‐ 372) 191 (92 ‐ 291)
South America 18 (12 ‐ 24) 10 (7 ‐ 14) 10 (5 ‐ 15) 5 (3 ‐ 8)
Oceania 1 (1 ‐ 1) 0 (0 ‐ 0) 1 (0 ‐ 1) 0 (0 ‐ 0)
World 640 (411 ‐ 857) 500 (321 ‐ 669) 362 (173 ‐ 551) 282 (135 ‐ 429)
Figure 3.1: Spatial distribution of annual non-accidental mortalities per 1000 km2
(left) and rate of non-accidental mortalities per 1E6 people (right) attributed to
anthropogenic ozone, when no threshold is assumed.
are high. However, cardiopulmonary mortalities per 1 million people are highest in
eastern Europe, due to high baseline cardiopulmonary mortality rates combined with
about average ozone concentrations.
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Figure 3.2: Spatial distribution of annual cardiopulmonary mortalities per 1000 km2
(left) and rate of cardiopulmonary mortalities per 1E6 people (right) attributed to
anthropogenic ozone, when no threshold is assumed.
3.2 Premature Mortality due to Anthropogenic PM
Premature all-cause, cardiopulmonary, and lung cancer mortalities resulting from
long-term PM exposure are shown in Table 3.2. Assuming no concentration thresh-
old, long-term PM exposure is estimated to result in 2.826 (95% CI, 0.996-4.852)
million all-cause mortalities (includes accidental and non-accidental causes) annually,
2.172 (95% CI, 0.786-3.533) million cardiopulmonary mortalities, and 192,000 (95%
CI, 63,000-282,000) lung cancer mortalities. When a low-concentration threshold of
7.5 µg/m3 is assumed, all-cause, cardiopulmonary, and lung cancer mortalities each
decrease by about half. Cardiopulmonary mortalities resulting from PM exposure are
about 77% of all-cause PM mortalities. Though lung cancer CRFs are much higher
than all-cause and cardiopulmonary CRFs, lung-cancer mortalities are only about 7%
of all-cause PM mortalities due to low baseline incidence rates. In all cases, about
three-quarters of mortalities occur in Asia. Europe has the second largest percent-
age of all-cause PM mortalities, mainly due to high PM concentrations and dense
population.
The geographic distribution of all-cause, cardiopulmonary, and lung cancer mor-
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Table 3.2: Annual all-cause, cardiopulmonary, and lung cancer mortalities resulting
from long-term anthropogenic PM exposure. Mortalities are based on the average of
1979-1983 and 1999-2000 CRFs from Pope et al. [2002] and 95% confidence intervals
are shown next to each estimate.
43 (15 76) 5 (2 8) 28 (10 48) 3 (1 5) 2 (1 3) 0 (0 0)
All‐Cause (000s) Cardiopulmonary (000s) Lung Cancer (000s)
threshold (μg/m3) 0 7.5 0 7.5 0 7.5
Africa 168 (58 ‐ 297) 9 (3 ‐ 16) 88 (31 ‐ 148) 5 (2 ‐ 9) 2 (1 ‐ 4) 0 (0 ‐ 0)
North America 115 (40 ‐ 202) 29 (10 ‐ 52) 77 (27 ‐ 130) 20 (7 ‐ 34) 15 (5 ‐ 23) 4 (1 ‐ 7)
Europe 442 (154 ‐ 768) 187 (65 ‐ 328) 357 (127 ‐ 591) 153 (54 ‐ 255) 40 (13 ‐ 59) 18 (6 ‐ 27)
Asia 2056 (729 ‐ 3506) 1269 (448 ‐ 2172) 1620 (591 ‐ 2615) 1006 (365 ‐ 1632) 132 (44 ‐ 193) 88 (29 ‐ 129)
South America     ‐     ‐     ‐     ‐     ‐     ‐ 
Oceania 2 (1 ‐ 3) 0 (0 ‐ 0) 1 (0 ‐ 2) 0 (0 ‐ 0) 0 (0 ‐ 0) 0 (0 ‐ 0)
World 2826 (996 ‐ 4852) 1499 (528 ‐ 2576) 2172 (786 ‐ 3533) 1187 (429 ‐ 1935) 192 (63 ‐ 282) 111 (36 ‐ 163)
Figure 3.3: Spatial distribution of annual all-cause mortalities per 1000 km2 (left)
and rate of all-cause mortalities per 1E6 people (right) attrubuted to anthropogenic
PM, when no threshold is assumed.
talities are shown in Figures 3.3, 3.4, and 3.5. Like the ozone results, these figures
show that the highest numbers of mortalities occur in population-dense areas. How-
ever, when the results are population-normalized as shown on the right in Figures
3.3, 3.4, and 3.5, the highest rates of mortalities per 1 million people are found in Eu-
rope, Asia, and the eastern US. Since PM has a shorter lifetime than ozone, high PM
concentrations are more localized, while ozone concentrations are more widespread
(Figure 2.1). Combined with high cardiopulmonary and lung cancer mortality rates
in these areas, high localized PM concentrations in Asia, Europe, and the eastern US
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Figure 3.4: Spatial distribution of annual cardiopulmonary mortalities per 1000 km2
(left) and rate of cardiopulmonary mortalities per 1E6 people (right) attributed to
anthropogenic PM, when no threshold is assumed.
Figure 3.5: Spatial distribution of annual lung cancer mortalities per 1000 km2 (left)
and rate of lung cancer mortalities per 1E6 people (right) due to anthropogenic PM,
when no threshold is assumed.
lead to high rates of PM mortality per 1 million people.
3.3 Sensitivity Analysis
We examine the sensitivity of mortality results to changing parameters, such as
concentration and CRFs (Tables 3.3 and 3.4). The effect of the ozone CRF was
tested by applying the average CRF from three meta-analyses of short-term ozone-
mortality studies published in 2005 [Bell et al., 2005; Ito et al., 2005; Levy et al.,
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2005]. The relationships between ozone and total mortality found by these studies
were consistent with each other and with Bell et al. [2004], which was the basis for the
ozone mortality results presented in Section 3.1. Applying the average of the median
CRFs from the three meta-analyses increases ozone mortality by about 20% (Table
3.3). The confidence interval for the results based on the three meta-analyses is based
on the lowest and highest values in the 95% confidence intervals of the CRFs found
by the three studies (not averages of the low and high ends).
We also examined the effect of ozone concentrations 25% lower and higher than the
concentrations simulated by MOZART-2 for both 1860 and 2000. Though modeled
concentrations were compared with observations and found to be generally unbiased,
we were only able to do comparisons in limited parts of the world where monitor
data are available. Therefore, we tested the effect of higher and lower ozone con-
centrations in case the modeled concentrations are biased in some way. With no
concentration threshold, ozone mortality estimates changed proportionally with the
changed concentration. However, when a concentration threshold of 25 ppb was ap-
plied, a 25% change in concentration resulted in a greater than proportional change
in mortalities (Table 3.3). This is likely due to the increased number of grid cells
with concentrations below the threshold when simulated concentrations are reduced
and the increased number of grid cells with concentrations above the threshold when
simulated concentration is increased.
Table 3.3: Sensitivity of ozone mortality results to changing parameters
Non‐Accidental (000s) Cardiopulmonary (000s)
threshold (ppb) 0 25 0 25
βBell et al. (2004) 640 (411 ‐ 857) 500 (321 ‐ 669) 362 (173 ‐ 551) 282 (135 ‐ 429)
βBell et al. (2004), 75% O3 481 (309 ‐ 644) 261 (168 ‐ 350) 272 (130 ‐ 415) 147 (70 ‐ 225)
βBell et al. (2004), 125% O3 798 (514 ‐ 1068) 717 (461 ‐ 959)   451 (217 ‐ 686) 404 (149 ‐ 614)
βmeta‐analyses 764 (440 ‐ 1415) 597 (344 ‐ 1106) n/a n/a
βBell et al. (2005) 693 (440 ‐ 1415) 541 (344 ‐ 1106)
βIto et al. (2005) 778 (520 ‐ 1013) 608 (406 ‐ 792)
βLevy et al. (2005) 822 (628 ‐ 1015) 643 (491 ‐ 794)We also examined the sensitivity of the PM mortality results to different CRFs.
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Table 3.4: Sensitivity of PM mortality results to changing parameters
β79 83 1937 (505 ‐ 3668) 1027 (268 ‐ 1947) 1508 (532 ‐ 2381) 823 (290 ‐ 1302) 119 (16 ‐ 213) 68 (9 ‐ 123)
All‐Cause (000s) Cardiopulmonary (000s) Lung Cancer (000s)
threshold (µg/m3) 0 7.5 0 7.5 0 7.5
βavg. 2826 (996 ‐ 4852) 1499 (528 ‐ 2576) 2172 (786 ‐ 3533) 1187 (429 ‐ 1935) 192 (63 ‐ 282) 111 (36 ‐ 163)
βavg., 75% PM2.5 2149 (751 ‐ 3726) 888 (310 ‐ 1542) 1662 (594 ‐ 2740) 711 (253 ‐ 1174) 148 (48 ‐ 221) 68 (22 ‐ 102)
βavg., 125% PM2.5 3485 (1239 ‐ 5925) 2150 (764 ‐ 3658) 2661 (976 ‐ 4273) 1684 (617 ‐ 2711) 232 (77 ‐ 336) 154 (51 ‐ 223)
‐                                    
βLaden et al. (2006) 6635 (3253 ‐ 9632) 3525 (1726 ‐ 5122) 5396 (2979 ‐ 7253) 2964 (1631 ‐ 3994) 316 (0 ‐ 552) 183 (0 ‐ 322)
Relative risk estimates for 1979-1983, 1999-2000, and the average of the two time
periods were reported by Pope et al. [2002]. Estimates for 1979-1983 are more con-
servative than the estimates for 1999-2000, which were used to drive the mortality
results in Section 3.2. About one-third fewer mortalities are predicted when the 1979-
1983 CRF is applied (Table 3.4). More recently, a reanalysis of the Harvard Six Cities
adult cohort study extended mortality follow-up for 8 years in a period of reduced air
pollution concentrations [Laden et al., 2006]. This study found significantly higher
relative risk estimates for overall mortality (1.16; 95% CI, 1.07-1.26) and mortality
due to cardiopulmonary disease (1.28; 95% CI, 1.13-1.44) and lung cancer (1.27; 95%
CI, 0.96-1.69) for a 10 µg/m3 increase in PM. When relative risks from Laden et al.
[2006] are applied, mortality results increases by a factor of 2 to 3 (Table 3.4).
For the results presented in Section 3.2, 100% of modeled sulfate, nitrate, OC,
and BC was assumed to be PM2.5, but the true PM2.5 fraction is likely to be between
50% and 100%. We test the effect of this assumption on mortality results by chang-
ing the fraction assumed to be PM2.5 to 75%. Since comparisons with observations
showed that simulated PM was generally biased high, reducing PM by 25% every-
where also tests the impact of reducing bias. We also tested the effect of increasing
simulated PM concentrations by 25% to determine the effect of limiting PM to only
four species (nitrates, sulfates, organic carbon, and black carbon). With no concen-
tration threshold, the PM mortality estimates change proportionally with the change
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in concentration (Table 3.4). However, like ozone, when a low-concentration thresh-
old is applied, a 25% change in concentration resulted in a greater than proportional
change in mortality. Again, this is most likely due to the increased number of grid
cells with concentrations below the threshold when simulated concentrations are re-
duced and the increased number of grid cells with concentrations above the threshold
when simulated concentration is increased.
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CHAPTER 4
SUMMARY AND CONCLUSIONS
The global burden of mortality due to anthropogenic ozone and PM was estimated
using a global atmospheric chemistry model and health impact functions. Depending
on the concentration threshold applied, anthropogenic ozone is associated with about
282,000 to 362,000 global premature cardiopulmonary mortalities, with uncertainty
ranging from 135,000 to 551,000 mortalities. Anthropogenic PM is associated with
about 1.3 to 2.4 million global premature cardiopulmonary and lung cancer mortal-
ities, with uncertainty ranging from 465,000 to 3.8 million mortalities. Cardiopul-
monary and lung cancer mortalities are presented here because they are not affected
by regional differences in baseline mortality rates when extrapolating US CRFs to
the global population. However, since ozone and PM may affect other causes of mor-
tality, these estimates are likely to be conservative and lower than our estimates for
non-accidental and total mortalities. The geographic distribution of results shows
that while the density of mortalities is highest in population-dense areas, mortalities
also occur in less populous areas that have been affected by the increased global back-
ground of air pollution since preindustrial times. Sensitivity analysis demonstrates
that these results are highly dependent on the assumptions on which the health im-
pact calculation is based.
These results are a factor of 3 higher than the 800,000 mortalities due to urban
PM estimated by Cohen et al. [2004], which applied the more conservative 1979-
1983 CRFs from Pope et al. [2002] and assumed a low-concentration threshold of 7.5
µg/m3. When the same assumptions for low-concentration thresholds and CRFs are
applied here, mortality estimates are still about 5% higher than those found in Cohen
et al. [2004], due to the inclusion of rural populations. The urban population included
in Cohen et al. [2004] was about 30% of the total global population. Mortalities are
likely to be underestimated due to the coarse grid size of the global atmospheric
chemistry model. Peaks in ozone and PM concentrations that usually occur in urban
areas are most likely subdued, due to averaging across the large grid cell. In addition,
only sulfates, nitrates, organic carbon, and black carbon were included here, leaving
out many other components of fine PM which contribute to urban and rural pollution.
Finally, PM CRFs were applied only to the population aged 30 and older, but evidence
suggests that PM affects health negatively for all ages, including the very young. For
these reasons, mortality results are most likely underestimates of the total global
burden of mortality due to anthropogenic air pollution.
Other limitations are associated with the assumptions made in this study. For
instance, the CRFs found by epidemiological studies conducted in North America
were assumed to apply to all other parts of the world. While some evidence exists to
validate this assumption, no PM cohort studies have yet been conducted in developing
countries. Differences in health status, lifestyle, age structure, and medical care
between developing and developed countries may have substantial consequences for
mortality due to anthropogenic air pollution. Until CRFs for the developing world
are established, less uncertainty is associated with estimating cause-specific mortality
than with estimating total mortality. Here, we calculated cardiopulmonary and lung
cancer mortality in addition to total mortality, finding slightly higher results than
Cohen et al. [2004] when using the same CRF and threshold.
Another limitation concerns the assumption that all PM species exert effects sim-
ilar to PM in the aggregate. Since CRFs are available only for fine PM or coarse
PM and not for specific PM components, this study aggregated black carbon, organic
carbon, nitrates, and sulfates into one category for fine PM. However, evidence sug-
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gests that particular PM components may be more deleterious to human health than
others [Ostro et al., 2007]. Since PM composition is drastically different through-
out the world, component-specific CRFs should be studied in further detail by daily
time-series and long-term cohort studies.
Despite these limitations, this study has important policy implications. The geo-
graphic distribution of mortalities highlights local areas and regions where improve-
ments to air quality may be particularly effective at reducing air pollution-related
mortality. As development in Asia continues at a fast pace, pollution levels are likely
to continue to increase in urban areas, as well as in rural areas where background con-
centrations will be elevated. Furthermore, as Asia develops, major causes of mortality
are shifting from infectious disease and malnutrition to chronic conditions, which are
more affected by air pollution exposure. Therefore, if continued unabated, air pollu-
tion is likely to have an even larger impact on mortality in the future than is estimated
for the present. The mortalities resulting from increases in both urban air pollution
and rural background air pollution are significant and should be considered during
national and international policymaking.
This study estimates that a greater number of premature mortalities is caused by
anthropogenic air pollution than were previously calculated. Global air quality models
are useful for estimating the global premature mortalities due to air pollution, despite
several important limitations in the necessary assumptions and data inputs. Future
studies using this method should incorporate CRFs from new studies on ozone and
PM mortality relationships, including those that examine individual PM components
and those that are conducted in different parts of the world. This method would also
benefit greatly by using statistical methods to correct for sub-grid scale urban peak
concentrations. Measurements taken in urban areas could be used to determine a
distribution of concentrations for the population within the coarse model grid cell.
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Population-weighted concentrations for urban grid cells could then be calculated and
applied in the mortality calculation. This would result in more accurate calculation
of mortalities for grid cells that surround urban areas.
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APPENDIX A
DERIVATION OF HEALTH IMPACT FUNCTION
A.1 Relative Risk Estimates from the Epidemiology Literature
Relative risk is the ratio of probability of a health endpoint occurring in an exposed
group versus an unexposed group. Here relative risk is determined by epidemiology
studies, which assess the risk of mortality in a group exposed to various air pollution
concentrations versus a group exposed to background air pollution concentrations
(unexposed group). A relative risk of 1 means there is no difference in risk between
the two groups. A relative risk greater than 1 indicates a greater risk of mortality for
the exposed group versus the unexposed group. A relative risk less than 1 indicates
a lesser risk of mortality for the exposed group versus the unexposed group.
Two methods for using relative risk to estimate the burden of disease due to air
pollution have been described in the literature. These methods have been referred to
differently by various studies. For simplicity, I refer to them as Method 1 and Method
2.
Method 1:
RR = expβ∆x (A.1)
Method 2:
RR =
[
x+ 0.0001
x0 + 0.0001
]β
(A.2)
Method 1 has been called “log-linear” [Cohen et al., 2004; Abt Associates, 2005]
or “linear” [Ostro, 2004]. Method 2 has also been called “log-linear” [Ostro, 2004].
With no threshold, relative risk predicted by the two methods diverge greatly, with
Method 2 predicting much higher than Method 1, as shown in Figure A.1. When a
low concentration threshold of 7.5 µg/m3 is applied, the curves representing Method
1 and Method 2 are closer together.
Figure A.1: Comparison of mortality calculation methods with no threshold applied
(top) and with a threshold of 7.5 µg/m3 (bottom)
Since mortalities are calculated here with no threshold applied, the choice of health
impact functions is significant. Method 1 is commonly used by the US Environmental
Protection Agency and health impact researchers. Method 2 is recommended by Ostro
[2004] and applied in a study estimating mortality due to ship emissions [Corbett
et al., 2007]. For this analysis, Method 1 was chosen because it is based on the
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concentration-response relationships found by Pope et al. [2002]. Pope et al. [2002]
plotted the natural logarithm of relative risk against PM2.5 concentration, showing
a nearly linear relationship. These results imply a log-linear relationship between
relative risk and PM2.5 concentration, as described by Method 1.
A.2 Derivation of the Health Impact Function
Attributable fraction is the fraction of the disease burden attributable to the risk
factor. It is calculated by Equation A.3.
AF =
RR− 1
RR
=
expβ∆X −1
expβ∆X
= 1− 1
expβ∆X
= 1− exp−β∆X (A.3)
where RR is relative risk and 1 denotes the relative risk of the unexposed population.
To calculate excess mortalities, the attributable fraction must then be multiplied
by the baseline mortality rate and exposed population to yield the number of mor-
talities attributable to air pollution (Equation A.4).
∆Y = Yo(1− exp−β∆X)Pop (A.4)
where ∆Y is excess mortalities, Yo is the baseline mortality rate, β is the concentration-
response factor, ∆X is the change in concentration, and Pop is the exposed popula-
tion.
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APPENDIX B
COMPARISONS OF MOZART-2 SIMULATED OZONE
CONCENTRATIONS WITH OBSERVED CONCENTRATIONS
Figure B.1: Comparison of simulated ozone (red) and CASTNet observations (black)
in 2000
Figure B.2: Comparison of simulated ozone (red) and EMEP observations (black) in
2000
Figure B.3: Comparison of simulated ozone in 2000 (red) and EANET observations
(black) in 2001
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Figure B.4: Comparison of simulated ozone in 2000 (red) and CMDL observations
(blue) from years 1998-2004
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APPENDIX C
POPULATION
Figure C.1: Spatial distribution of 2006 population from Landscan database [Oak
Ridge National Laboratory, 2008]
per km 2
Figure C.2: Spatial distribution of 2006 population from Landscan database [Oak
Ridge National Laboratory, 2008] summed to MOZART-2 grid
Figure C.3: Fraction of population aged 30 and older from World Health Organization
[2004] mapped onto MOZART-2 grid
per km 2
Figure C.4: Population aged 30 and older calculated from Landscan population [Oak
Ridge National Laboratory, 2008] and fraction of population aged 30 and older from
World Health Organization [2004] mapped onto MOZART-2 grid
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APPENDIX D
BASELINE MORTALITY RATES
% per year
Figure D.1: Baseline all-cause mortality rates mapped onto MOZART-2 grid
% per year
Figure D.2: Baseline all-cause mortality rates for population aged 30 and older
mapped onto MOZART-2 grid
% per year
Figure D.3: Baseline non-accidental mortality rates mapped onto MOZART-2 grid
% per year
Figure D.4: Baseline non-accidental mortality rates for population aged 30 and older
mapped onto MOZART-2 grid
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% per year
Figure D.5: Baseline cardiopulmonary mortality rates mapped onto MOZART-2 grid
% per year
Figure D.6: Baseline cardiopulmonary mortality rates for population aged 30 and
older mapped onto MOZART-2 grid
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per year
Figure D.7: Baseline lung cancer mortality rates mapped onto MOZART-2 grid
per year
Figure D.8: Baseline lung cancer mortality rates for population aged 30 and older
mapped onto MOZART-2 grid
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